RSV Vaccines in Adults: A Risk-Based Approach
Listen to Angela Branche, MD, share her perspective on why healthcare professionals should consider a risk-based approach—rather than age alone—to determine RSV vaccine candidacy in adults.
Decera Clinical Education Infectious Disease Podcast · Angela Branche MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including:
- Current Advisory Committee on Immunization Practices recommendations
- Risk factors associated with severe RSV disease, including RSV-related hospitalizations
- Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine
- Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities
- Health disparities related to RSV vaccines
- Considerations for a risk-based approach, rather than age alone, to determine vaccine candidacy
Faculty:
Angela Branche, MD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York
Link to full program:
https://bit.ly/3nb25xe
Link to downloadable slides:
https://bit.ly/3TsXym5
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.